Home > Qtrly Results > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Quarterly Results Analysis [Sep2023]

TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Quarterly Results

Consolidated Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
Audited
Sep2022
UnAudited
Jun2022
UnAudited
Mar2022
Audited
Dec2021
Audited
Revenues ₹2,660 Cr ₹2,591 Cr ₹2,491 Cr ₹2,491 Cr ₹2,291 Cr ₹2,347 Cr ₹2,131 Cr ₹2,108 Cr
Expenses ₹1,835 Cr ₹1,800 Cr ₹1,764 Cr ₹1,767 Cr ₹1,612 Cr ₹1,635 Cr ₹1,570 Cr ₹1,570 Cr
Operating Income ₹825 Cr ₹791 Cr ₹727 Cr ₹724 Cr ₹679 Cr ₹712 Cr ₹561 Cr ₹538 Cr
Other Income ₹26 Cr ₹34 Cr ₹9 Cr ₹-10 Cr ₹16 Cr ₹30 Cr ₹56 Cr ₹48 Cr
Interest ₹91 Cr ₹103 Cr ₹107 Cr ₹102 Cr ₹69 Cr ₹55 Cr ₹57 Cr ₹62 Cr
Depreciation ₹201 Cr ₹191 Cr ₹196 Cr ₹193 Cr ₹163 Cr ₹155 Cr ₹162 Cr ₹167 Cr
Profit Before Tax ₹559 Cr ₹531 Cr ₹433 Cr ₹419 Cr ₹463 Cr ₹532 Cr ₹-87 Cr ₹357 Cr
Profit After Tax ₹386 Cr ₹378 Cr ₹287 Cr ₹283 Cr ₹312 Cr ₹354 Cr ₹-118 Cr ₹249 Cr
EPS ₹11.40 ₹11.17 ₹8.48 ₹8.36 ₹9.22 ₹10.46 ₹-3.49 ₹7.36
Industry Peers & Returns1W1M1Y
TORRENT PHARMACEUTICALS -2.3% 5.9% 27.9%
SUN PHARMACEUTICAL INDUSTRIES 1% 7.9% 18.5%
DIVIS LABORATORIES -1.4% 6.6% 9.4%
CIPLA -0.5% 0.1% 8.9%
DR REDDYS LABORATORIES -1% 7.3% 29.2%
ABBOTT INDIA -2.9% -0.9% 12.5%
ZYDUS LIFESCIENCES -0.4% 8.7% 54%
ALKEM LABORATORIES 0.1% 23.7% 48.7%
LUPIN -2.9% 3.6% 63.4%

TORRENT PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

2.66 %

Y-o-Y

16.11 %

Quarters Revenues % Change
Sep2023 ₹2,660 Cr
2.66
Jun2023 ₹2,591 Cr
4.01
Mar2023 ₹2,491 Cr
0.00
Dec2022 ₹2,491 Cr
8.73
Sep2022 ₹2,291 Cr
-2.39
Jun2022 ₹2,347 Cr
10.14
Mar2022 ₹2,131 Cr
1.09
Dec2021 ₹2,108 Cr -

TORRENT PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

4.30 %

Y-o-Y

21.50 %

Quarters Operating Profit % Change
Sep2023 ₹825 Cr
4.30
Jun2023 ₹791 Cr
8.80
Mar2023 ₹727 Cr
0.41
Dec2022 ₹724 Cr
6.63
Sep2022 ₹679 Cr
-4.63
Jun2022 ₹712 Cr
26.92
Mar2022 ₹561 Cr
4.28
Dec2021 ₹538 Cr -
Operating Margins
Q-o-Q

1.60 %

Y-o-Y

4.66 %

Quarters Operating Margin% % Change
Sep2023 31.02%
1.60
Jun2023 30.53%
4.59
Mar2023 29.19%
0.45
Dec2022 29.06%
-1.96
Sep2022 29.64%
-2.31
Jun2022 30.34%
15.23
Mar2022 26.33%
3.17
Dec2021 25.52% -

TORRENT PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

2.12 %

Y-o-Y

23.72 %

Quarters Profit After Tax % Change
Sep2023 ₹386 Cr
2.12
Jun2023 ₹378 Cr
31.71
Mar2023 ₹287 Cr
1.41
Dec2022 ₹283 Cr
-9.29
Sep2022 ₹312 Cr
-11.86
Jun2022 ₹354 Cr
Positive
Mar2022 ₹-118 Cr
Negative
Dec2021 ₹249 Cr -
PAT Margins
Q-o-Q

-0.55 %

Y-o-Y

6.53 %

Quarters PAT Margin(%) % Change
Sep2023 14.51 %
-0.55
Jun2023 14.59 %
26.65
Mar2023 11.52 %
1.41
Dec2022 11.36 %
-16.59
Sep2022 13.62 %
-9.68
Jun2022 15.08 %
Positive
Mar2022 -5.54 %
Negative
Dec2021 11.81 % -

TORRENT PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

2.06 %

Y-o-Y

23.64 %

Quarters EPS % Change
Sep2023 ₹11.4
2.06
Jun2023 ₹11.17
31.72
Mar2023 ₹8.48
1.44
Dec2022 ₹8.36
-9.33
Sep2022 ₹9.22
-11.85
Jun2022 ₹10.46
Positive
Mar2022 ₹-3.49
Negative
Dec2021 ₹7.36 -

You may also like the below Video Courses


SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].